Compile Data Set for Download or QSAR
Report error Found 27 Enz. Inhib. hit(s) with all data for entry = 8677
TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM103940(US8569338, 7 | US9493457, 7 | US9035066, 7 | US989...)
Affinity DataIC50: 34nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM103941(US8569338, 14 | US9493457, 14 | US9035066, 14 | US...)
Affinity DataIC50: 48nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM103942(US8569338, 24 | US9493457, 17 | US9035066, 17 | US...)
Affinity DataIC50: 91nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM412604(US10399973, Example 24 | (3R)-1-methylpyrrolidin-3...)
Affinity DataIC50: 1.00E+3nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM412605(US10399973, Example 25 | Oxetan-2-ylmethyl 4-isopr...)
Affinity DataIC50: 1.00E+3nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM412606(US10399973, Example 26 | 2-(Pyridin-3-yloxy)ethyl ...)
Affinity DataIC50: 1.00E+3nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM412607(US10399973, Example 27 | 2-(2,2,2-Trifluoroethoxy)...)
Affinity DataIC50: 1.00E+3nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM412600(US10399973, Example 20 | (2R)-Tetrahydrofuran-2-yl...)
Affinity DataIC50: 1.00E+3nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM412601(US10399973, Example 21 | 1,3-Thiazol-2-ylmethyl 4-...)
Affinity DataIC50: 1.00E+3nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM412602(US10399973, Example 22 | (5-Methylisoxazol-3-yl)me...)
Affinity DataIC50: 1.00E+3nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM412603(US10399973, Example 23 | [(2S)-1-Methylpyrrolidin-...)
Affinity DataIC50: 1.00E+3nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM412596(US10399973, Example 15 | 2-(4-Chlorophenoxy)ethyl ...)
Affinity DataIC50: 1.00E+3nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM412597(US10399973, Example 16 | (3S)-Tetrahydrofuran-3-yl...)
Affinity DataIC50: 1.00E+3nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM412598(US10399973, Example 18 | (3-Methyloxetan-3-yl)meth...)
Affinity DataIC50: 1.00E+3nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM412599(US10399973, Example 19 | 2-(Dimethylamino)ethyl 4-...)
Affinity DataIC50: 1.00E+3nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM412592(US10399973, Example 10 | Pyrazin-2-ylmethyl 4-isop...)
Affinity DataIC50: 1.00E+3nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM412593(US10399973, Example 11 | Benzyl (4S,6S)-6-(aminoca...)
Affinity DataIC50: 1.00E+3nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM412594(US10399973, Example 12 | Benzyl (4S,6S)-4-isopropy...)
Affinity DataIC50: 1.00E+3nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM412595(US10399973, Example 13 | 5-Benzyl 6-methyl (4S,6S)...)
Affinity DataIC50: 1.00E+3nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM412588(US10399973, Example 5 | 4-Chlorobenzyl 4-isopropyl...)
Affinity DataIC50: 1.00E+3nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM412589(US10399973, Example 6 | Pyridin-2-ylmethyl 4-isopr...)
Affinity DataIC50: 1.00E+3nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM412590(US10399973, Example 8 | Pyridin-4-ylmethyl 4-isopr...)
Affinity DataIC50: 1.00E+3nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM412591(US10399973, Example 9 | (5-Chloropyridin-2-yl)meth...)
Affinity DataIC50: 1.00E+3nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM412584(US10399973, Example 1 | 2,2,2-Trichloroethyl 4-iso...)
Affinity DataIC50: 1.00E+3nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM412585(US10399973, Example 2 | 2-Chloro-2,2-difluoroethyl...)
Affinity DataIC50: 1.00E+3nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM412586(US10399973, Example 3 | Benzyl 4-isopropyl-1,4,6,7...)
Affinity DataIC50: 1.00E+3nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
Ligand InfoPurchaseSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Benevolentai Cambridge

US Patent
LigandPNGBDBM412587(US10399973, Example 4 | 3-Chlorobenzyl 4-isopropyl...)
Affinity DataIC50: 1.00E+3nMAssay Description:All assays were performed in room temperature with purified recombinantly expressed human SSAO. Enzyme was prepared essentially as described in hman ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent